What is the ticker symbol for Impel Pharmaceuticals?

Impel Pharmaceuticals trades under the ticker IMPL on NASDAQ.

What sector does Impel Pharmaceuticals operate in?

Impel Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IMPL in a portfolio?

PortView shows IMPL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Impel Pharmaceuticals (IMPL) Stock Analysis

NASDAQHealthcareBiotechnology

$0.04-27.27%

1-year price historyRange $0.04 – $3.61

52-week range$0.04

$0.02$4.20

What Impel Pharmaceuticals does

Impel Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical firm, concentrating its efforts on creating and commercializing therapies for individuals in the United States who are affected by central nervous system (CNS) conditions. Leading its product portfolio is Trudhesa, an innovative upper nasal formulation of dihydroergotamine, specifically engineered for the prompt relief of acute migraine attacks. Furthermore, the company's development pipeline encompasses INP105, another upper nasal medication containing olanzapine, currently being advanced for the rapid treatment of agitation and aggressive behaviors associated with autism spectrum disorder. Impel is also progressing with INP107, an intranasal carbidopa/levodopa compound, which has already successfully concluded its Phase IIa clinical trial aimed at managing "OFF" episodes in Parkinson's disease patients. Initially established in 2008, the company was formerly known as Impel NeuroPharma, Inc. before rebranding to Impel Pharmaceuticals Inc. in April 2022. Its corporate headquarters are situated in Seattle, Washington.

Key metrics

Market cap

$956,000

P/E (TTM)

-0.01

EPS (TTM)

$-3.12

Beta

1.17

Dividend yield

0.00%

Revenue / share

$0.54

50-day avg

$0.34

200-day avg

$0.97

52-week high

$4.20

52-week low

$0.02

CEO

Leonard S. Paolillo

ETFs linked to IMPL

Broad-market and Healthcare sector ETFs an investor holding Impel Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how IMPL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IMPL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Impel Pharmaceuticals?: Impel Pharmaceuticals trades under the ticker IMPL on NASDAQ.
Which exchange is IMPL listed on?: IMPL is listed on NASDAQ.
What sector does Impel Pharmaceuticals operate in?: Impel Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IMPL in a portfolio?: PortView shows IMPL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.